Figure 1
Median paclitaxel concentration in the absence (day 1) or presence (day 15) of lapatinib and pazopanib at the MTR (paclitaxel 80 mg m −2 , pazopanib 400 mg, and lapatinib 1000 mg).
Figure 1 | British Journal of Cancer
Median paclitaxel concentration in the absence (day 1) or presence (day 15) of lapatinib and pazopanib at the MTR (paclitaxel 80 mg m −2 , pazopanib 400 mg, and lapatinib 1000 mg).
